What are the treatment options for skin infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Skin Infections

First-Line Treatment Recommendations

For skin and soft tissue infections, amoxicillin-clavulanate is the first-line treatment option due to its excellent coverage against common pathogens including Staphylococcus aureus, streptococci, and anaerobic bacteria. 1

Classification of Skin Infections

Skin infections can be classified as:

  • Uncomplicated SSTIs: Superficial infections carrying low risk for life-threatening complications

    • Examples: Impetigo, erysipelas, mild cellulitis, simple abscesses
    • Treatment: Empiric antibiotic therapy or drainage and debridement
  • Complicated SSTIs: Deep infections with high risk for life-threatening complications

    • Examples: Necrotizing infections, infected ulcers, major abscesses, surgical/traumatic wound infections
    • Treatment: Broad-spectrum antibiotics and surgical intervention

Treatment Algorithm Based on Infection Type

1. Non-purulent Cellulitis (Likely Streptococcal)

  • First-line: Penicillin V or amoxicillin
  • Alternative: Cephalexin 500 mg four times daily for 7-10 days
  • Penicillin-allergic patients: Clindamycin or doxycycline

2. Purulent Skin Infections (Likely Staphylococcal)

  • Primary treatment: Incision and drainage for abscesses 2
  • Antibiotic therapy:
    • MRSA not suspected: Dicloxacillin, cephalexin, or amoxicillin-clavulanate
    • MRSA suspected or confirmed: TMP-SMX, doxycycline, or minocycline 2

3. Mixed Infections (Animal Bites)

  • First-line: Amoxicillin-clavulanate 875/125 mg twice daily for 5-7 days 1
  • Alternatives: Ampicillin-sulbactam, piperacillin-tazobactam, carbapenems
  • Penicillin-allergic patients: Doxycycline or fluoroquinolones plus clindamycin 1

4. Complicated Skin Infections

  • Inpatient treatment options:
    • Vancomycin IV 2
    • Linezolid 600 mg IV/PO twice daily 2, 3, 4
    • Daptomycin 4 mg/kg IV once daily 2
    • Telavancin 10 mg/kg IV once daily 2
    • Ceftaroline IV 2
    • Dalbavancin IV 2

5. Fungal Skin Infections

  • Topical treatment: Clotrimazole, miconazole, or nystatin 2
  • Keep affected areas dry 2

Special Considerations

MRSA Infections

  • Oral options:

    • Trimethoprim-sulfamethoxazole (TMP-SMX) 2
    • Doxycycline or minocycline 2
    • Linezolid 600 mg twice daily 2
    • Tedizolid 2
  • Intravenous options (for severe infections):

    • Vancomycin 2
    • Linezolid 2
    • Daptomycin 2
    • Ceftaroline 2

Animal Bites

  • First-line: Amoxicillin-clavulanate 875/125 mg twice daily for 5-7 days 1
  • Immediate wound care: Gentle irrigation with water or dilute povidone-iodine solution 1
  • Tetanus prophylaxis: If vaccination status outdated or unknown 1
  • Rabies prophylaxis: Consider for wild animal bites; consult local health department 1

Duration of Therapy

  • Uncomplicated infections: 5-7 days 1
  • Complicated infections: 7-14 days, individualized based on clinical response 2
  • Switch from IV to oral therapy when clinical stability is achieved 2

Common Pitfalls to Avoid

  1. Failing to drain abscesses: Incision and drainage is the primary treatment for abscesses, with antibiotics being adjunctive therapy 2, 5

  2. Inappropriate antibiotic selection: Consider local resistance patterns when selecting empiric therapy, particularly for MRSA coverage 2

  3. Inadequate wound care: Proper wound irrigation and debridement are as important as antibiotics for preventing infection 1

  4. Delayed treatment of necrotizing infections: These require immediate surgical debridement and broad-spectrum antibiotics 2

  5. Suturing high-risk wounds: Avoid suturing animal bites and contaminated wounds as it increases infection risk 1

  6. Overlooking special populations: Immunocompromised patients, diabetics, and those with peripheral vascular disease require more aggressive treatment and monitoring 2, 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.